Mutations of NPHS1 or NPHS2, the genes encoding for the glomerular podocyte proteins nephrin and podocin, cause steroid-resistant proteinuria. In addition, mice lacking NEPH1 develop a nephrotic syndrome that resembles NPHS mutations, suggesting that all three proteins are essential for the integrity of glomerular podocytes. Podocin interacts with the C-terminal domain of nephrin and facilitates nephrin-dependent signaling. NEPH1, a member of the immunoglobulin superfamily, is structurally related to nephrin. We report now that NEPH1 belongs to a family of three closely related proteins that interact with the C-terminal domain of podocin. All three NEPH proteins share a conserved podocin-binding motif; mutation of a centrally located tyrosine residue dramatically lowers the affinity of NEPH1 for podocin. NEPH1 triggers AP-1 activation similarly to nephrin but requires the presence of Tec family kinases for efficient transactivation. We conclude that NEPH1 defines a new family of podocinbinding molecules that are potential candidates for hereditary nephrotic syndromes not linked to either NPHS1 or NPHS2.
. We have recently demonstrated that nephrin is a signaling molecule that activates canonical protein kinase cascades (5) . Podocin interacts with the carboxy-terminal, cytoplasmic domain of nephrin (6) , and greatly enhances nephrin-induced signaling (5) . NEPH1, a molecule recently identified in mice by a retrovirus-mediated mutagenesis screen, contains five extracellular immunoglobulin-like domains and is structurally related to nephrin (7) . NEPH1 is abundantly expressed in the kidney, and disruption of the NEPH1 gene in mice results in effacement of glomerular podocytes, heavy proteinuria, and early postnatal death (7) . We report here that NEPH1 belongs to a family of three closely related proteins that bind to the C-terminal domain of podocin. All three NEPH proteins share a conserved podocin-binding motif. Mutation of a conserved tyrosine residue present in all three NEPHs dramatically lowers the affinity of NEPH1 for podocin, indicating that this tyrosine residue is of critical importance for the interaction between podocin and NEPH1.
MATERIALS AND METHODS

Materials
The podocin antiserum has recently been described (8) . The anti-Flag (M2) antisera was purchased from Sigma-Aldrich (Taufkirchen, Germany), and the protein G-sepharose was obtained from Amersham Pharmacia Biotech (Freiburg, Germany). The secondary antisera were obtained from Jackson Immuno Research Laboratories (West Grove, PA). The NEPH1 antiserum was generated by immunization of a rabbit with purified bacterial recombinant maltose binding (MBP) fusion protein MBP.NEPH1 65-234. The obtained antiserum was affinity purified vs. bacterial recombinant glutathione-S-transferase (GST) fusion protein of NEPH1, GST.NEPH1 65-234. The Grb2 (C-23) antiserum was purchased from Santa Cruz Biotechnology (Heidelberg, Germany) and the phospho-tyrosine-specific antibody 4G10 from Upstate Biotechnology (Lake Placid, NY). The human podocyte lines were recently described (13) .
Cloning of mouse NEPH family members
The cDNA sequence of human NEPH1 (AY017369) was used to search the GenBank database to identify an overlapping human clone (AK001707) containing the 3'-end of the NEPH1-cDNA. Homology searches with the human clone (AK001707) lead to a mouse EST-clone (AV311860) that covers the 3'-end of mNEPH1. The full-length cDNA of mNEPH1 was isolated by polymerase chain reaction (PCR), using a mouse fetal brain cDNA-library (Edge Biosystems, Gaithersburg, MD) with the 5'-oligonucleotide 5'-ATGACTCTGGAGAGCCCTAGC and the 3'-oligonucleotide 5'-CTACACATGAGTCTGCATGCGCTG (AF480411). Using the mNEPH1 cDNA sequence, we identified two additional homologous genes, termed NEPH2 (AF480410) and NEPH3 (XM_048304), by GenBank database searches. The full-length cDNA of NEPH2 was isolated by PCR, using a human fetal brain library in combination with the 5'-oligonucleotide 5'-ATGAAACCCTTCCAGCTC and the 3'-oligonucleotide 5'-TTAGACGTGAGTCTGCATCCG. The full-length cDNA of NEPH3 was isolated by PCR from the DKFZ clone DKFZp564A1164 using the 5'-oligonucleotide 5'-ATGCTCAGGATGCGGGTC and the 3'-oligonucleotide 5'-TCACACGTGAGTCTGGAGACG.
Plasmids
The human nephrin and mouse podocin constructs were recently published. Membrane-bound fusions of the C-terminal domains of NEPH1, NEPH2, and NEPH3 were expressed in HEK 293T cells by using a derivative of pCDM8 containing the leader sequence of CD5 fused to the CH2 and CH3 domain of human IgG1 followed by the transmembrane region of CD7 as previously described (9) . The point mutations of NEPH1 were generated by PCR. The podocin and CD2AP cDNA-plasmids have been described previously (5) . The Itk cDNA was a gift from K. Sugamura (10), the Tec cDNA was a gift from H. Mano, and the PDZK1 cDNA was a gift from O. Kocher (11) . Flag-tagged versions were generated by polymerase chain reaction and standard cloning techniques. The v-src cDNA plasmid was a gift from V. Sukhatme, and the Grb2 cDNA was a gift from I. Dikic.
Coimmunoprecipitation
Coimmunoprecipitations were performed as previously described (12) . In brief, HEK 293T cells were transiently transfected by the calcium phosphate method. After incubation for 24 h, cells were washed twice and lysed in a 1% Triton X-100 lysis buffer. After centrifugation (15,000g, 15 min, 4°C), cell lysates containing equal amounts of total protein were incubated for 1 h at 4°C with the appropriate antibody followed by incubation with 40 µl of protein G-sepharose beads for ∼3 h. The beads were washed extensively with lysis buffer, and bound proteins were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). For interaction of endogenous proteins, cultured, differentiated mouse podocytes were lysed in 20 mM Tris, pH 7.5; 30 mM NaCL; 50 mM NaF; 25 mM Na 4 P 2 O; and 0.1 mM EDTA, supplemented with 20 mM of CHAPS. After centrifugation (15,000g, 15 min, 4°C) and ultracentrifugation (100,000g, 30 min, 4°C), cell lysates containing equal amounts of total protein were precleared with protein G-sepharose and then incubated for 1 r at 4°C with the podocin antiserum, followed by incubation with 40 µl of protein G-sepharose beads for ∼3 h. The beads were washed extensively with lysis buffer, and bound proteins were resolved by 10% SDS-PAGE.
Luciferase assay
HEK 293T cells seeded in 12-well plates were transiently transfected with a luciferase reporter construct, a β-galactosidase expression vector (kindly provided by C. Cepko), and vectors directing the expression of the proteins as indicated. Total DNA amount was 1.5-2.5 µg/well. Cells were serum starved for 12 h, harvested in cold PBS, and lysed in 100 µl of reporter lysis buffer (Applied Biosystems, Norwalk, CT) for 15 min at room temperature. Lysates were centrifuged at 14,000 rpm for 5 min to remove insoluble material. Luciferase activity was determined using a commercial assay system (Applied Biosystems) following the manufacturer's instructions and was normalized for β -galactosidase activity to correct for the transfection efficiency.
Immunofluorescence
Paraffin sections of adult mouse kidneys were fixed overnight in DMSO/methanol, embedded, and sectioned. After standard immunohistological, procedures, including antigen retrieval with citrate buffer (pH 6.0), the sections were incubated with affinity-purified anti-NEPH1 antiserum followed by anti-rabbit rhodamine red. An Axiophot 2 microscope (Zeiss, Jena) equipped with a CCD camera was used for image documentation.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR was performed as previously described (13) . For detection of human NEPH1, the 5'-oligonucletotide 5'-CTGCCACCATCATCTGGTTC and 3'-oligonucleotide 5'-GTGCTGACATTGGTGCTTCC were used to yield a 448-bp fragment. For detection of human NEPH2, the 5'-oligonucletotide 5'-CATCATCTCCAGCACCCAGA and 3'-oligonucleotide 5'-TGCCATAAGGACGAGGAAGG were used to yield a 400-bp fragment. For detection of human NEPH3, the 5'-oligonucletotide 5'-ATTTCCTGCAACAGCCAGA and 3'-oligonucleotide 5'-CAGGGTTAAGGTGCTCTCCA were used to yield a 501-bp fragment.
RESULTS
NEPH1 is a member of three structurally related proteins
We searched GenBank for NEPH1-related proteins and identified two closely related family members that we termed NEPH2 and NEPH3. All three proteins belong to the immunoglobulin superfamily (Fig. 1A) and share a common domain architecture consisting of five extracellular immunoglobulin-like repeats followed by a transmembrane domain and a cytoplasmic domain of about 198-235 amino acids. The Motif Scanner (http://scansite.mit.edu/) revealed that the cytoplasmic domain of all three proteins contains a conserved Grb2 SH2-binding site, located within a stretch of nine conserved amino acids, and a C-terminal PDZK1-binding site (Fig. 1B ) (14) . Indeed, NEPH1 interacts with both Grb2 and PDZK1 in transiently transfected HEK 293T cells (Fig. 1C) . A survey of the EST database and published data revealed that podocin and the NEPH family members have a similar tissue distribution (Fig. 1D) . Podocin is expressed in the kidney, testis, fetal heart, and liver (4). NEPH1 EST database entries are derived from placenta, renal tumor cell lines, teratocarcinoma cell line, and melanoma cell line cDNA libraries, and expression has been reported in the kidney (glomerular mesangium, proximal tubules, and collecting ducts) brain, smooth muscle of liver, lung, and heart of the newborn mouse (7) . NEPH2 is present in the brain, heart, nervous system, and lung carcinoma cell line, whereas NEPH3 is present in the kidney, lung, pituitary, germ cell, and several tumor cell lines. All three proteins are present in the central nervous system (CNS) or CNS-derived tumor cell lines (Fig.  1D) . RT-PCR revealed that all three NEPHs are expressed in a human podocyte cell line (Fig.  1E) . Furthermore, all three NEPHs are expressed in the cortex of the human kidney (Fig. 1F) . To detect endogenous NEPH1, a NEPH1-specific antiserum was generated ( Fig. 2A, 2B ). Indirect immunofluorescence revealed that the NEPH1 antiserum outlines the glomerular basal membrane (Fig. 2C, 2D ).
NEPH proteins interact with podocin
Targeted deletion of NEPH1 causes proteinuria and early postnatal death in mice (7) . Because nephrin shares structural and sequence similarities with NEPH1, we speculated that NEPH1 interacts with podocin. As demonstrated in Figure 3A , Flag-tagged podocin coimmunoprecipitated with NEPH1. Using a podocin-and NEPH1-specific antiserum, we determined that this interaction was also detectable in immortalized mouse podocytes (Fig. 3B) and was mediated through the C-terminal domain of podocin (Fig. 3C) . To demonstrate that the C-terminal domain of the NEPH proteins mediated the interaction, we fused the C-terminal domains of all three NEPH proteins and nephrin to the CH2 and CH3 domains of human immunoglobulin G, which was proceeded by a leader sequence (5) . Figure 3D demonstrates that the C-terminal domain of all four proteins--nephrin, NEPH1, NEPH2, and NEPH3--immobilized podocin, and Figure 3E shows that a short stretch of nine conserved amino acids (KDPTNGYYxV) present in all three NEPH molecules appears to mediate the interaction with podocin. Because nephrin shares the tyrosine at position 637 with NEPH1, we generated a NEPH1 Y637A mutant. As shown in Figure 3F , this point mutation substantially inhibits the NEPH1-podocin interaction. Although we cannot exclude the possibility that the Y637A mutations alter the overall structure of the podocin-binding domain, our results indicate that the tyrosine at position 637 is essential for the interaction of NEPH1 with podocin. Interestingly, the replacement of proline with serine at position 633, also conserved in all three NEPHs, did not abolish binding of podocin to NEPH1. This finding prompted us to speculate that the interaction between podocin and NEPH1 is regulated by a protein kinase that recognizes the PxxxY motif and phosphorylates tyrosine 637. Because NEPH1 contains a binding site for the SH2 domain of Itk, and the PxxxY motif can be found in substrates of the src-kinase family (15), NEPH1 was coexpressed with Itk and v-src. As demonstrated in Figure 3G , both protein kinases reduced the interaction of the C-terminal domain of NEPH1 with podocin.
NEPH1 is a signaling molecule
All NEPH family members contain a putative Grb2 SH2 binding site (Fig. 1) , indicating that NEPH molecules can activate canonical signaling cascades. Because expression of nephrin in HEK cells activates the transcription factor AP-1, we compared the transactivation mediated by nephrin and NEPH1. As demonstrated in Figure 4A , nephrin, NEPH1, and NEPH2 trigger a significant increase in AP-1 activation in transiently transfected HEK 293T cells. NEPH3 was poorly expressed and therefore not tested. The NEPH1-mediated transactivation was less striking than the activation induced by nephrin, and podocin had only a modest effect on the NEPH1-mediated AP-1 activation (Fig. 4B) . Because NEPH1 contains an Itk SH2 binding site, we analyzed whether Itk affected the NEPH1-mediated AP-1 activation. Itk by itself had little effect (Fig. 4C) ; however, in combination with NEPH1, Itk triggered a substantial increase in AP-1 activation, suggesting that Itk or other members of the Tec family are required for efficient downstream signaling of NEPH1. Both Itk and Tec substantially increased tyrosine phosphorylation of NEPH1 (Fig. 4D) .
DISCUSSION
A database search with the NEPH1 sequence revealed two NEPH1-related proteins that we have termed NEPH2 and NEPH3. All three proteins share a common domain architecture with five immunoglobulin-like (Ig) repeats, a transmembrane domain, and a cytoplasmic tail with two highly conserved domains containing Grb2-and PDZK1-binding sites. The presence of several extracellular C2-type Ig repeats suggests that these molecules participate in adhesive interactions with other cells or the extracellular matrix. NEPH1 is the best characterized member of this novel family (7): It is present in the glomerular podocyte, and targeted disruption of NEPH1 results in a nephrotic syndrome that resembles human disease caused by nephrin or podocin mutations (4, 7, 16) . We report here that NEPH1 shares with nephrin the ability to interact with the carboxy-terminal domain of podocin. Both nephrin and podocin localize to the slit diaphragm, a zipper-like membrane formed between neighboring podocyte-foot processes (6) . The phenotypic similarities reported for nephrin-and NEPH1-deficient mice are highly suggestive that NEPH1 is also a component of the slit diaphragm, although our antiserum was not suitable to determine the precise sublocalization of NEPH1 by electron microscopy.
Nephrin and podocin associate with lipid rafts (6), a microdomain that consists of assemblies of sphingolipids and cholesterol in the outer leaflet of the plasma membrane. The composition of lipid rafts is highly dynamic (see review in ref 17) , but the process that includes or excludes proteins from these microdomains is currently not well understood. Src and Tec protein kinases inhibit the interaction between podocin and NEPH1, suggesting that tyrosine phosphorylation regulates the interaction between NEPH1 and podocin and perphaps the recruitment of NEPH1 into lipid rafts. Tec protein kinases were first identified in the immune system, where they are required for proper lymphocyte activation and development. However, it is now apparent that Tec kinases are widely expressed and contribute to multiple functions; they are essential for activation of phospholipase Cγ and other downstream signaling events and participate in signal transduction of growth factor receptors, cytokine receptors, G protein-coupled receptors, antigen receptors, and integrins (see review in ref 18 ). An emerging role of Tec family kinases is the cytoskeletal reorganization, cellular migration, and regulation of the barrier function of epithelial cells (18, 19) . At least two family members, Bmx and Tec, can be found in the kidney (20) . Interestingly, Tec kinases as well as the doubly acylated Src-family kinases belong to a group of proteins with increased affinity for lipid rafts (17, 21, 22) . Because lipid rafts form a new microenvironment, where the phosphorylation state of surface proteins can be modified by local kinases and phosphatases, it is conceivable that podocin recruits NEPH1 to lipid rafts, where Tec-or Src-family kinases mediate the tyrosine phosphorylation of NEPH1 and perhaps its disssociation from lipid rafts.
All three NEPHs can be detected in a human glomerular podocyte cell line by using RT-PCR. Although their precise glomerular localization needs to be determined, our findings suggest that all three NEPHs are present in glomerular podocytes. The NEPH3 gene is located on chromosome 19q13.1 immediately adjacent to the NPHS1 gene. It will be important to examine whether some patients with a hereditary nephrotic syndrome and an apparent linkage with the NPHS1 gene may in fact suffer from mutations in the NEPH3 gene. . B) Alignment of the C-terminal cytoplasmic domain of the three NEPH members, mouse NEPH1 (AF480411), human NEPH2 (AF480410), and human NEPH3 (XM_048304), using Clustal (Megalign, DNASTAR). All three proteins contain a highly conserved stretch of 10 amino acids, located at position 631-640 of NEPH1, and share the C-terminal four amino acids (RxQTHV). NEPH1 and NEPH2 are most closely related (20.5% identity); the identity between NEPH1 and NEPH3 averages 14.1%. C) Interaction between Grb2 and PDZK1. In the left panel, HEK 293T cells were transiently transfected with Grb2 and either the control protein sIg.7 or sIg.7.NEPH1. After immunoprecipitation of the Ig-containing proteins with protein G, the interacting Grb2 was detected by Western blot analysis. In the right panel, Flag-tagged gfp or -PDZK1 were cotransfected with NEPH1. After immunoprecipitation of Flag-tagged proteins with the Flag-specific M2 antibody, the interacting NEPH1 was detected by Western blot analysis. The lower panel demonstrates equal expression of the precipitated protein in the control condition. D) Expression pattern of podocin and NEPH family members, using EST database entries and published data (4, 7). E) RT-PCR detects specific transcripts for NEPH1 (448 bp), NEPH2 (400 bp), and NEPH3 (501 bp) in human podocytes. F) Expression of all three NEPH proteins can be demonstrated in the cortex of the human kidney, using RT-PCR. Note that NEPH2 is poorly expressed in the renal medulla, suggesting a more limited renal expression pattern than the other NEPH proteins. 2 . Generation of NEPH1-specific antiserum. A) A NEPH1-specific antiserum was generated in rabbits, using a MBP-NEPH1 fusion protein that contains amino acids 65-234 of NEPH1. Western blot analysis demonstrates that the antiserum specifically recognizes NEPH1. B) The affinity-purified antiserum detects NEPH1 in lysates of transiently transfected HEK293T cells and in lysates of mouse kidneys. C) The NEPH1-antiserum specifically labels glomerular cells, whereas a control antiserum displays no specific staining (D). Depicted are images at 630×, generated with a Zeiss Axiophot 2 microscope. Luciferase and β-galactosidase activity were determined 24 h after transfection. All experiments were performed in triplicate and confirmed in at least three independent experiments. B) Podocin mediates only a modest increase of NEPH1-mediated AP-1 activation. C) Coexpression of NEPH1 and Itk leads to a significant increase of the NEPH1-mediated AP-1 transactivation, whereas Itk itself had little effect. D) Itk and Tec increase the tyrosine phosphorylation of the C-terminal domain of NEPH1. HEK 293T cells were transfected with plasmids as indicated. Approximately 24 h after transfection, cellular lysates were separated on SDS-PAGE. Western blot analysis was performed, using the phospho-tyrosine specific antibody 4G10.
